Victoria Sung

1.4k total citations
33 papers, 903 citations indexed

About

Victoria Sung is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Victoria Sung has authored 33 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Hematology. Recurrent topics in Victoria Sung's work include Erythrocyte Function and Pathophysiology (5 papers), Hemoglobinopathies and Related Disorders (5 papers) and Bone health and treatments (4 papers). Victoria Sung is often cited by papers focused on Erythrocyte Function and Pathophysiology (5 papers), Hemoglobinopathies and Related Disorders (5 papers) and Bone health and treatments (4 papers). Victoria Sung collaborates with scholars based in United States, Switzerland and Australia. Victoria Sung's co-authors include David Feldman, Erik W. Thompson, Alan D. Aaron, Larry W. Fisher, John T. Stubbs, Rajesh Chopra, Ronald Hoffman, Jiapeng Wang, Goar Mosoyan and Thomas Kraus and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Victoria Sung

33 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victoria Sung United States	17	356	256	223	218	136	33	903
Wei Xie United States	17	370 1.0×	203 0.8×	165 0.7×	220 1.0×	60 0.4×	55	986
Andrey Zaritskey Russia	14	202 0.6×	429 1.7×	505 2.3×	248 1.1×	234 1.7×	66	1.0k
Stephen B. Marley United Kingdom	16	394 1.1×	384 1.5×	264 1.2×	281 1.3×	75 0.6×	23	956
Cristina Panaroni United States	14	377 1.1×	248 1.0×	129 0.6×	231 1.1×	70 0.5×	31	908
Joanne I. Adamkewicz United States	13	373 1.0×	733 2.9×	237 1.1×	219 1.0×	65 0.5×	24	1.4k
Audrey Cras France	19	421 1.2×	153 0.6×	352 1.6×	94 0.4×	37 0.3×	43	950
Shihong Lu China	19	440 1.2×	270 1.1×	387 1.7×	198 0.9×	32 0.2×	59	1.1k
Henrik Lilljebjörn Sweden	22	588 1.7×	673 2.6×	226 1.0×	338 1.6×	184 1.4×	51	1.6k
Xinyan Lu United States	20	280 0.8×	375 1.5×	313 1.4×	292 1.3×	47 0.3×	58	969
Simona Berardi Italy	18	423 1.2×	331 1.3×	71 0.3×	321 1.5×	76 0.6×	37	970

Countries citing papers authored by Victoria Sung

Since Specialization

Citations

This map shows the geographic impact of Victoria Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Sung more than expected).

Fields of papers citing papers by Victoria Sung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Sung. The network helps show where Victoria Sung may publish in the future.

Co-authorship network of co-authors of Victoria Sung

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Sung. A scholar is included among the top collaborators of Victoria Sung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Sung. Victoria Sung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Richards, John O., Robyn J. Puro, Gabriela Andrejeva, et al.. (2020). AO-176, a Highly Differentiated Clinical Stage Anti-CD47 Antibody, Exerts Potent Anti-Tumor Activity in Preclinical Models of Multiple Myeloma As a Single Agent and in Combination with Approved Therapeutics. Blood. 136(Supplement 1). 3–4. 12 indexed citations

Cappellini, Maria Domenica, John B. Porter, Raffaella Origa, et al.. (2018). Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study. Haematologica. 104(3). 477–484. 68 indexed citations

Zheng, Bing, Piu Wong, Wenqing Yang, et al.. (2017). Abstract 2009: CC-90002 (anti-CD47 antibody) in vivo anti-tumor activity is associated with an increase in M1-polarized macrophages. Cancer Research. 77(13_Supplement). 2009–2009. 3 indexed citations

Ear, Jason, Qinghua Zhang, Victoria Sung, et al.. (2016). A Zebrafish Model of 5q-Syndrome Using CRISPR/Cas9 Targeting RPS14 Reveals a p53-Independent and p53-Dependent Mechanism of Erythroid Failure. Journal of genetics and genomics. 43(5). 307–318. 28 indexed citations

Sugatani, Toshifumi, Olga A. Agapova, Yifu Fang, et al.. (2016). Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease. Kidney International. 91(1). 86–95. 42 indexed citations

Langdon, Jacqueline M., Alan E. Berger, Chris Cheadle, et al.. (2014). RAP‐011, an activin receptor ligand trap, increases hemoglobin concentration in hepcidin transgenic mice. American Journal of Hematology. 90(1). 8–14. 28 indexed citations

Heise, Carla, et al.. (2013). Sotatercept, An Activin Receptor-2a Ligand Trap, Modulates Hepcidin Levels In Primary Human Hepatocytes. Blood. 122(21). 3441–3441. 1 indexed citations

Ear, Jason, Haigen Huang, Victoria Sung, et al.. (2013). RAP-011 Efficiently Rescues Erythropoiesis In Zebrafish Models Of Diamond Blackfan Anemia. Blood. 122(21). 3702–3702. 1 indexed citations

Cappellini, Maria Domenica, John B. Porter, Raffaella Origa, et al.. (2013). A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results. Blood. 122(21). 3448–3448. 14 indexed citations

10.

Salvatorelli, Emanuela, Pierantonio Menna, Odalys Gonzalez Paz, et al.. (2012). Pharmacokinetic Characterization of Amrubicin Cardiac Safety in an Ex Vivo Human Myocardial Strip Model. II. Amrubicin Shows Metabolic Advantages over Doxorubicin and Epirubicin. Journal of Pharmacology and Experimental Therapeutics. 341(2). 474–483. 28 indexed citations

11.

Iancu‐Rubin, Camelia, Goar Mosoyan, Jiapeng Wang, et al.. (2012). Stromal cell-mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trap. Experimental Hematology. 41(2). 155–166.e17. 82 indexed citations

12.

Salvatorelli, Emanuela, Pierantonio Menna, Sekhar Surapaneni, et al.. (2012). Pharmacokinetic Characterization of Amrubicin Cardiac Safety in an Ex Vivo Human Myocardial Strip Model. I. Amrubicin Accumulates to a Lower Level than Doxorubicin or Epirubicin. Journal of Pharmacology and Experimental Therapeutics. 341(2). 464–473. 9 indexed citations

13.

Dussiot, Michaël, Thiago Trovati Maciel, Aurélie Fricot, et al.. (2012). Modulation of Activin Signaling by RAP-011 (ActRIIA-IgG1) Improve Anemia, Increases Hemoglobin Levels and Corrects Ineffective Erythropoiesis in β-Thalassemia. Blood. 120(21). 247–247. 1 indexed citations

14.

Carrancio, Soraya, Jennifer A. Markovics, Piu Wong, et al.. (2012). Sotatercept, an Activin Receptor IIa Ligand Trap, Acts Through Bone Marrow Accessory Cells to Promote Late-Stage Erythropoiesis and a Rapid Induction of Red Blood Cell Number and Hemoglobin. Blood. 120(21). 372–372. 1 indexed citations

15.

Sung, Victoria, et al.. (2011). Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells. Cancer Science. 102(6). 1201–1207. 20 indexed citations

16.

Pryer, Nancy, Victoria Sung, Ursula Jeffry, et al.. (2009). Abstract #DDT02-2: MCS110: a monoclonal antibody with potent neutralizing activity against macrophage colony-stimulating factor for the treatment of tumor-induced osteolysis. Cancer Research. 69. 1 indexed citations

17.

Sung, Victoria, et al.. (2003). The Ste20 kinase MST4 plays a role in prostate cancer progression.. PubMed. 63(12). 3356–63. 42 indexed citations

18.

Sharp, Julie A., Victoria Sung, Joanne Slavin, Erik W. Thompson, & Henderson. (1999). Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.. PubMed. 79(7). 869–77. 18 indexed citations

19.

Sung, Victoria, John T. Stubbs, Larry W. Fisher, Alan D. Aaron, & Erik W. Thompson. (1998). Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the αvβ3 and αvβ5 integrins. Journal of Cellular Physiology. 176(3). 482–494. 111 indexed citations

20.

Sung, Victoria, Christine Gilles, Robert Clarke, et al.. (1998). The LCC15-MB Human Breast Cancer Cell Line Expresses Osteopontin and Exhibits an Invasive and Metastatic Phenotype. Experimental Cell Research. 241(2). 273–284. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact